Lumos Diagnostics Holdings Ltd - Asset Resilience Ratio

Latest as of December 2025: 14.18%

Lumos Diagnostics Holdings Ltd (LDX) has an Asset Resilience Ratio of 14.18% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Lumos Diagnostics Holdings Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$2.99 Million

≈ $2.12 Million USD Cash + Short-term Investments

Total Assets

AU$21.12 Million

≈ $14.94 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Lumos Diagnostics Holdings Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see LDX total assets.

Liquid Assets Composition Over Time

This chart breaks down Lumos Diagnostics Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Lumos Diagnostics Holdings Ltd for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.99 Million	14.18%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.99 Million	14.18%

Asset Resilience Insights

Moderate Liquidity: Lumos Diagnostics Holdings Ltd has 14.18% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Lumos Diagnostics Holdings Ltd Industry Peers by Asset Resilience Ratio

Compare Lumos Diagnostics Holdings Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
TransMedics Group Inc NASDAQ:TMDX	Medical Devices	0.00%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Hangzhou AGS MedTech Co. Ltd. A SHG:688581	Medical Devices	18.80%
Nanjing Vishee Medical Technology Co Ltd SHG:688580	Medical Devices	10.74%
Nanjing Medlander Medical Technology Co. Ltd. A SHG:688273	Medical Devices	34.29%

Annual Asset Resilience Ratio for Lumos Diagnostics Holdings Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Lumos Diagnostics Holdings Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.40%	AU$1.96 Million ≈ $1.38 Million	AU$20.81 Million ≈ $14.73 Million	-14.74pp
2023-12-31	24.14%	AU$6.48 Million ≈ $4.58 Million	AU$26.84 Million ≈ $18.99 Million	+12.28pp
2022-12-31	11.86%	AU$3.02 Million ≈ $2.13 Million	AU$25.42 Million ≈ $17.99 Million	-9.74pp
2021-12-31	21.60%	AU$7.98 Million ≈ $5.64 Million	AU$36.94 Million ≈ $26.14 Million	-24.21pp
2020-12-31	45.81%	AU$44.89 Million ≈ $31.76 Million	AU$97.99 Million ≈ $69.33 Million	+43.00pp
2019-12-31	2.81%	AU$850.30K ≈ $601.64K	AU$30.28 Million ≈ $21.42 Million	-9.05pp
2018-12-31	11.86%	AU$3.01 Million ≈ $2.13 Million	AU$25.40 Million ≈ $17.97 Million	+9.31pp
2017-12-31	2.55%	AU$226.43K ≈ $160.21K	AU$8.89 Million ≈ $6.29 Million	--

pp = percentage points

About Lumos Diagnostics Holdings Ltd

AU:LDX Australia Medical Devices

Market Cap

$71.91 Million

AU$101.63 Million AUD

Market Cap Rank

#20573 Global

#692 in Australia

Share Price

AU$0.11

Change (1 day)

+10.00%

52-Week Range

AU$0.08 - AU$0.32

All Time High

AU$1.22